Grifols: Solid Q3 Execution, But Cash Conversion And 2026 Risks Keep Us Neutral
Source: SeekingAlpha
2025-12-28 09:10:00 ET
Building on our latest Q1 update, we return to Grifols ( GRFS ) to assess recent developments. At first glance, the company reported a solid quarter; however, we remain on the sidelines. Our view has been validated so far; Grifols’ total return is down 7.94% since the Q1 update (including its dividend payment - Fig. 1)....
Read the full article on Seeking Alpha
For further details see:
Grifols: Solid Q3 Execution, But Cash Conversion And 2026 Risks Keep Us Neutral
Grifols S.A.
NASDAQ: GRFS
GRFS Trading
-3.13% G/L:
$8.055 Last:
499,195 Volume:
$8.19 Open:
GRFS Latest News
GRFS Stock Data
$6,538,647,175
559,676,571
N/A
69
N/A
Pharmaceuticals
Healthcare
ES
Sant Cugat del Valles
